TokenPost·
AbbVie Raises Full-Year Guidance as Non-GAAP EPS Beats Estimates
Third-quarter revenue reached $17.4 billion, up 10.3% year over year, while the immunology portfolio generated $9.165 billion in global net revenue.
More news
- TokenPostHashKey RWA Launches First hToken Security With USDT Subscriptions
- TokenPost18,270 Bitcoin Tied to Binance Incident Splits Across 19 Wallets
- Bitcoin.com NewsCZ Tells Elon Musk to Stop Trolling Over $6.3B Binance Hack, Cites SpaceX Stake
- The DefiantUniswap, a16z and DEF Seek DeFi Exemptions From Illinois Crypto Tax Rules
- TokenPostDragonfly Partner Says Binance Hack Drew a Muted Market Response
- TokenPostExxon CEO Points to Diesel as a Key Refined-Fuel Pressure Point